Pfenex Company

Pfenex develops biosimilar therapeutics and novel vaccines for the treatment and prevention of critical human health issues.
Headquartered in San Diego, California, nex Inc. is a leading biotechnology company focused on recombinant protein expression for a broad range of applications including therapeutic proteins, vaccines, research, reagents and biosimilars. The Company's core technology, Pfēnex Expression Technology™, is a cutting edge protein expression platform that utilizes the BSL-1 microorganism Pseudomonas fluorescens. Pfēnex Expression Technology™ combines an extensive toolbox of expression components with a robotically enabled high throughput parallel strain screening technology, delivering unprecedented speed and success in identifying protein production strains expressing high titers of soluble active protein.
Technology: Preventive Medicine
Industry: Precision Medicine
Headquarters: San Diego
Founded Date: 2009
Employees Number: 11-50
Funding Status: IPO

Visit Website
proteins@pfenex.com
https://www.twitter.com/pfenex
Register and Claim Ownership